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METHODS
CONCLUSIONS
• EGR-1 is regulator of FAS, MIC-1, and PDGF-A expression
• This novel analysis between cell models and human tissues 
is helpful identifying pathways in prostate field cancerization
• EGR-1, FAS, MIC-1, and PDGF-A are markers that can 
lead to improvements in prostate field cancerization 
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QUESTION
Is EGR-1 a master regulator of prostate field cancerization?
PURPOSE: understand field cancerization on the molecular 
level by identifying function pathways
Figure 4. Tissues adjacent to tumors may undergo morphological changes leading to molecular alterations that are in 
complete absence of any cytological or histological change. These molecular alterations can involve changes in 
expression for several protein factors: early growth response 1 (EGR-1), the lipogenic enzyme fatty acid synthase 
(FAS), and the secreted growth factors platelet derived growth factor A (PDGF-A) and macrophage inhibitory cytokine 
1 (MIC-1). As a key transcription factor, we hypothesis EGR-1 is a master regulator of FAS, MIC-1, and PDGF-A. 
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• Ratio of either FAS, MIC-1, and 
PDGF-A  to EGR-1 expression
• High ratios suggest a potential 
regulatory role of EGR-1
• EGR-1 is regulator of FAS, 
MIC-1, and PDGF-A expression
• Ratio of MIC-1 to EGR-1 
expression increased 
significantly in adjacent and 
tumor tissues (p<0.05)
Figure 7. Pearson’s correlation (r) shows the association between high EGR-1 expression and FAS, MIC-1, and 
PDGF-A expression in disease-free, adjacent, and tumor tissues. General trends of EGR-1 regulation of FAS, 
MIC-1, and PDGF-A expression are represented by blue arrows. 
• EGR-1, FAS, MIC-1, 
and PDGF-A have 
greater expression in 
adjacent tissue, which 
can be a molecular 
mechanism of field 
cancerization
RESULTS: Human Tissues
Figure 5. Representative immunofluorescence image.
Figure 6. The ratio of either FAS, MIC-1, or PDGF-A to EGR-1 
expression in disease-free compared to adjacent and tumor 
tissues determined a potential regulatory function of EGR-1.
Figure 9. Elevated EGR-1 
expression results in up-regulated 
FAS and MIC expression and down-
regulated PDGF-A expression in cell 
models and human tissues. Vertical 
arrows indicated strong regulation, 
while slanted arrows represent 
moderate regulation. 
    
RESULTS: Cell Models
• EGR-1 is a regulator of 
FAS, MIC-1, and PDGF-A 
expression
• EGR-1 down-regulated 
FAS and MIC-1 expression 
by 70% and 30% in PC-3 
cells (p=0.005, p=0.015)
• EGR-1 up-regulated 
PDGF-1 expression by 110-
fold in PC-3 cells (p=0.004)
                              
Figure 8.  qRT-PCR results show the effect of EGR-1 
over expression on FAS, MIC-1, PDGF-A mRNA 
expression in cell models: RWPE-1, LNCaP, and  PC-3.
           
BACKGROUND
Demographics of prostate cancer: 
• 2nd leading cause of cancer-related death of men in USA
• 30,000 men die each year (one death every 17 minutes)
• 80% men before the age of 80 are diagnosed
• 233,000 men are diagnosed each year [1]
Field Cancerization: Molecular alterations in structurally 
intact cells residing in histologically normal tissues adjacent to 
tumors [3]
Significance: Increase clinically informative area as it pertains 
to prostate biopsies for confirmatory diagnosis of cancer [4]
• Our lab identified 
four protein factors as 
markers of field 
cancerization [5,6]
Figure 1. The prostate is a walnut sized gland 
found in males that is located below the bladder.
Figure 2. Improved dianosis of prostate cancer 
involves markers of field cancerization.
Figure 3. Avoiding false 
negative biopsies through 
the use of markers of field 
cancerization. (A) Biopsy 
cores (blue circles) miss 
the tumor foci (red irregular 
structure). (B) The field 
associated with the tumor 
(dotted circle) is detected 
by the biopsies (blue 
circles).
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